17 results
·
19ms
·
Sources: EU EUDAMED, US FDA
Anti Snore Mouthpiece
FDA 510(k)
FDA Class 2
·Dental
Waxed Dental Floss
FDA UDI
SAFCO DENTAL SUPPLY CO.·10810063756656·Waxed Dental Floss, unflavored, 12 yds - sample...
APEX Knee System
FDA UDI
Omni Life Science, Inc.·00841690129790·Modular Tibia Fluted Keel Stem, Size 12mm x 100mm
ELMED
FDA UDI
ELMED INCORPORATED·00842180136939·ADAPTER FOR ELECTRODE HANDLE FOR CONNECTING MON...
ELMED
FDA UDI
ELMED INCORPORATED·00842180136922·PISTOL GRIP SUCTION/IRRIGATION HANDLE ONLY
Prosthesis, Intervertebral Disc
FDA Pre-Market Approval
FDA Class 3
·Synergy Disc
Zimmer Segmental System XT Components
FDA 510(k)
FDA Class 2
·Orthopedic
MAESTRO CARPAL HEMIARTHROPLASTY
FDA 510(k)
FDA Class 2
·Orthopedic
Prosthesis, Intervertebral Disc
FDA Pre-Market Approval
FDA Class 3
·Synergy Disc
Widex
FDA UDI
Widex A/S·05706069898125·WIDEX EVOKE E-CIC (Clay brown ) 100, Left, RC coil
DEXCOM G6 CONTINUOUS GLUCOSE MONITORING SYSTEM
FDA Adverse Event
Malfunction
·DEXCOM, INC.·Product code QBJ·September 8, 2025
E SERIES DEFIBRILLATOR
FDA Adverse Event
Malfunction
·ZOLL MEDICAL CORPORATION·Product code MKJ·November 13, 2008
MCA LARGE APPLIER
FDA Adverse Event
Malfunction
·ETHICON ENDO-SURGERY, LLC.·Product code GDO·September 15, 2011
AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR
FDA Adverse Event
Injury
·C.R. BARD, INC. (COVINGTON)·Product code OTP·July 24, 2013
Venclose digiRF Generators, Model VCRFG1, with software 3.35 designed to identify internal wiring anomalies in the Venclose EVSRF Ablation Catheter prior to use. The Venclose digiRF Generator is a sophisticated multi-voltage energy delivery system featuring touchscreen control that automatically configures non-adjustable treatment parameters (including time and temperature) for compatible catheters connected via a triaxial connector port. Designed for use with Venclose RF Catheters (either the EVSRF or Maven variants) as an integrated system, the device employs resistive radiofrequency ablation to deliver temperature-controlled RF energy that heats incompetent vein walls, inducing irreversible luminal occlusion followed by progressive fibrosis and eventual vein resorption. The 510(k) submission K250068 encompasses solely the Venclose digiRF Generator due to software modifications with no alterations to the cleared Venclose Catheters (EVSRF and Maven variants, cleared under K160754 and K211806, respectively).
FDA Enforcement
Class II
·Ongoing·Bard Peripheral Vascular Inc·October 8, 2025
Venclose digiRF Generators, Model VCRFG1, with software 3.35 designed to identify internal wiring anomalies in the Venclose EVSRF Ablation Catheter prior to use. The Venclose digiRF Generator is a sophisticated multi-voltage energy delivery system featuring touchscreen control that automatically configures non-adjustable treatment parameters (including time and temperature) for compatible catheters connected via a triaxial connector port. Designed for use with Venclose RF Catheters (either the EVSRF or Maven variants) as an integrated system, the device employs resistive radiofrequency ablation to deliver temperature-controlled RF energy that heats incompetent vein walls, inducing irreversible luminal occlusion followed by progressive fibrosis and eventual vein resorption. The 510(k) submission K250068 encompasses solely the Venclose digiRF Generator due to software modifications with no alterations to the cleared Venclose Catheters (EVSRF and Maven variants, cleared under K160754 and K211806, respectively).
FDA Recall
Open, Classified
·Bard Peripheral Vascular Inc
1625 W 3rd St Bldg 1
850 W. Rio Salado Prkwy.
Tempe AZ 85281-2438·Product code GEI·August 21, 2025
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models F102, F110, F111. Sterilized using ethylene oxide. Boston Scientific, 4100 Hamline Avenue North, St. Paul, MN 55112-5798 USA. Indicated for patients who are at risk for sudden cardiac death due to ventricular arrhythmias and may require pacing support.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 23, 2013